Apobiologix is proud to be a Canadian pharmaceutical company with a singular focus on biosimilar

development and commercialization. Established in 2015, we are a division of Apotex, a

Canadian-based global health company.

At Apobiologix, we are committed to building on our heritage in oncology and expanding our

expertise to other therapeutic areas to help broaden our offering to patients and healthcare

professionals.

At Apobiologix, we believe that access to medications should not be limited by financial barriers

but should be a fundamental right for every Canadian – and we continually strive to bridge the gap

between affordability and quality therapeutics.

Through innovation and collaboration, we are confident in our future, and look forward to pursuing

our collective goals in patient support and sustainability.

Together, our vision is limited only by our imagination.

© 2025, Apotex Inc.

ANSWERS patient support program is sponsored by Apobiologix®, a division of Apotex Inc.

Apobiologix®, and the ANSWERS® patient support program logo are registered trademarks owned by

Apotex Inc.

GRAS-0011-2024-CAN

Apobiologix is a Proudly Canadian Company

Apobiologix is a division of Apotex Inc.